Filter news by date News Tags - Any -Key releaseNews storyPress release Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Year Year202320222021202020192018201720162015201420132012201120102009200820072006 Apply 9 . 16 . 2022 Press release Galderma debuts the Sensitive Skincare Faculty, a global expert group to improve understanding and management of sensitive skin 9 . 6 . 2022 Press release Galderma showcases its continued commitment to innovation in dermatology with new data to be presented at 2022 EADV congress 8 . 25 . 2022 Press release Galderma delivers strong H1 2022 results and continued innovation across its leading dermatology portfolio 6 . 30 . 2022 Press release Galderma and Children’s Skin Disease Foundation Celebrate Decade-Long Partnership 6 . 22 . 2022 Press release Galderma announces positive data from phase III trial, demonstrating efficacy and safety of nemolizumab in patients with prurigo nodularis 6 . 10 . 2022 Press release Galderma announces positive results in two phase III studies for a novel liquid formulation botulinumtoxinA (RelabotulinumtoxinA) for the treatment of glabellar lines (frown) and lateral canthal lines (crow’s feet) 6 . 8 . 2022 Press release Galderma to present new findings from innovative product portfolio at the 2022 VCS Annual Symposium 6 . 2 . 2022 Press release Galderma Launches EPSOLAY® Cream, a Medical Advance to Treat Bumps and Blemishes of Rosacea 6 . 1 . 2022 News story Actinic Keratosis prevention campaign encourages everyone to ‘FACE THE FACTS’ 5 . 31 . 2022 Press release Galderma to present extensive new clinical data across its portfolio of neuromodulators, fillers and biostimulators at the IMCAS World Congress 2022 4 . 25 . 2022 Press release Sol-Gel Technologies and Galderma Announce FDA Approval of EPSOLAY® 4 . 6 . 2022 Press release Cetaphil® debuts global sensitive skin awareness initiative Pagination Previous page Previous Page Next page Next Page